关于以集中竞价交易方式回购公司股份的进展公告 证券代码：688315 证券简称：诺禾致源 公告编号：2024-052 北京诺禾致源科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： | 回购方案首次披露日 | 2024/2/6，由实际控制人、董事长兼总经理李瑞 强提议 | | | --- | --- | --- | | 回购方案实施期限 | 年 2 月 5 日第三届董事会第十五次会议审 | 2024 | | | 议通过后 12 个月 | | | 预计回购金额 | 8,000 万元~16,000 万元 | | | 回购用途 | □减少注册资本 √用于员工持股计划或股权激励 | | | | □用于转换公司可转债 | | | | □为维护公司价值及股东权益 | | | 累计已回购股数 | 1,114.15 万股 | | | 累计已回购股数占总股本比例 | 2.68% | | | 累计已回购金额 | 14,414.75 万元 | | | 实际回购价格区间 | 元/股~15.86 元/股 | 9.69 ...

证券代码：688315 证券简称：诺禾致源 公告编号：2024-051 北京诺禾致源科技股份有限公司 关于召开 2024 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 会议召开时间：2024 年 11 月 29 日(星期五)下午 13:00-14:00 会 议 召 开 地 点 ： 上海证券 交 易 所 上 证 路 演 中 心 （ 网 址 ： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2024 年 11 月 22 日(星期五)至 11 月 28 日(星期四)16:00 前 登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 ir@novogene.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行回 答。 北京诺禾致源科技股份有限公司（以下简称"公司"）已于 2024 年 10 月 25 日发布公司 2024 年第三季度报告，为便于广大投资者更全面深入地了解公司 2024 年第三季度经营成果、 ...

证券研究报告 | 公司动态点评 2024 年 11 月 03 日 诺禾致源（688315.SH） 盈利能力边际改善，全球本土化稳步推进 | --- | --- | --- | --- | --- | --- | --- | --- | |--------------------------------------------|-------|-------|-------|-------|-------|------------------------------------------|----------| | 财务指标 | 2022A | 2023A | 2024E | 2025E | 2026E | 买入（维持评级） | | | | | | | | | | | | 营业收入（百万元） | 1,926 | 2,002 | 2,174 | 2,445 | 2,766 | 股票信息 | | | 增长率 yoy （ % ） | 3.2 | 4.0 | 8.6 | 12.5 | 13.1 | | | | 归母净利润（百万元） | 177 | 178 | 195 | 222 | 259 | 行业 | 医药 | | ...

Investment Rating - The report maintains a "Buy" rating for the company [3] Core Views - The company demonstrated stable operations in Q3 2024, with revenue growth of 4.68% year-on-year and net profit growth of 12.52% [1] - The improvement in profit growth compared to revenue is attributed to a decrease in expense ratio and an increase in fair value changes [1] - The establishment of laboratories in Germany and Japan enhances the company's global service capabilities [1] - The Falcon system's upgrade significantly boosts production efficiency across global laboratories [1] - The company is focused on innovation and efficiency, with a notable increase in published SCI articles and the development of advanced delivery systems [1] Financial Performance Summary - For Q1-Q3 2024, the company achieved revenue of 1.519 billion, a year-on-year increase of 6.31%, and a net profit of 134 million, up 7.33% [1] - In Q3 2024, revenue reached 523 million, with a net profit of 56.53 million, reflecting a 12.52% increase [1] - The net profit margin for Q3 was 11.03%, an increase of 0.59 percentage points year-on-year [1] - The company expects revenues of 2.141 billion, 2.414 billion, and 2.747 billion for 2024, 2025, and 2026 respectively, with corresponding net profits of 201 million, 249 million, and 313 million [2][9] Operational Highlights - The company has expanded its overseas business, generating 501 million in revenue in H1 2024, accounting for 50.26% of total revenue [1] - The global service network covers approximately 90 countries and regions, serving around 7,300 clients [1] - The company continues to enhance its local presence with new laboratories in key international markets [1] Future Outlook - The company anticipates revenue growth rates of 6.9%, 12.8%, and 13.8% for the years 2024, 2025, and 2026 respectively [2] - The projected net profit growth rates are 13.1%, 23.5%, and 25.6% for the same periods [2]

北京诺禾致源科技股份有限公司 关于以集中竞价交易方式回购公司股份的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： | 回购方案首次披露日 | | 2024/2/6，由实际控制人、董事长兼总经理李瑞强 | | --- | --- | --- | | | 提议 | | | 回购方案实施期限 | 2024 年 2 月 5 | 日第三届董事会第十五次会议审议 | | | 通过后 个月 12 | | | 预计回购金额 | 8,000 万元~16,000 万元 | | | 回购用途 | □减少注册资本 √用于员工持股计划或股权激励 | | | | □用于转换公司可转债 | | | | □为维护公司价值及股东权益 | | | 累计已回购股数 | 1,114.15 万股 | | | 累计已回购股数占总股本比 | 2.68% | | | 例 | | | | 累计已回购金额 | 14,414.75 万元 | | | 实际回购价格区间 | 9.69 元/股~15.86 元/股 | | 证券代码：688315 证券简称： ...

参 与 单 位 名 称 民生证券：朱凤萍；东吴证券：张坤等 72 人。 及人员姓名 证券代码：688315 证券简称：诺禾致源 北京诺禾致源科技股份有限公司投资者关系活动记录表 编号：014 | --- | --- | --- | |-------------------|----------------------------|---------------------------------| | | | | | | £ 特定对象调研 □分析师会议 | | | 投 资 者 关 系 活 | □ 媒体采访 | 业绩说明会 | | 动类别 | □ 新闻发布会 □路演活动 | | | | £ 现场参观 | | | | □ | 其他 （请文字说明其他活动内容） | | --- | --- | --- | |-------------------|------------------------------------------|------------------------| | 时间 | 2024 年 10 月 24 日（周四） | 21：00-22 ： 00 | | 地点 | 公司会议室 | | | | 董 ...

主要是分享这些本地实验室的服务能力我们还会再结合我们的产品撤走我们的产品规划去增加新的品类去满足更多的客户需求这个是我们目前海外的实验室的考虑另外整个产能上就是 现在这个阶段刚才我在分享的时候也说过就是处于一个旅进设备的一个切换阶段整个海外的整个Nova就是我们原来的Nova 6000和现在的Apple Watch基本上这个Nova 6000就是在海外实验室基本上是退出已经退出的一个状态那我们基本上现在就切到这个Apple WatchApple Watch这个也是目前还在查货阶段嘛基本上这个在这个 一到九月三个季度到现在看的话基本上三个季度看的话基本上也到五成到六成那个水平吧大概是这样的谢谢明白非常清楚我一点没有其他问题了下面有请问8939的三规则进行提问谢谢 - 喂 请问可以听到您的声音吗?- 可以- 您好 我是现场征券的医药研究员乔嘉宁- 然后我这边的话主要是想跟公司请教两个小一点的问题- 一个的话就是我们的比较小型的业务- 就单细胞侧序和质谱这一块大概前三季度的一个业务体量和一个增长情况是什么样的- 然后另外第二个问题的话 其实我们也看到现在国内的话也是因为有江西江州的一些影响的话企业的投融资情况也开始 ...

证券代码：688315 证券简称：诺禾致源 公告编号：2024-048 北京诺禾致源科技股份有限公司 关于 2024 年前三季度计提资产减值准备的公告 北京诺禾致源科技股份有限公司（以下简称"公司"）于 2024 年 10 月 24 日召 开第三届董事会第十九次会议、第三届监事会第十七次会议，分别审议通过了《关 于计提资产减值准备的议案》。现将相关事项公告如下： 一、计提资产减值准备情况的概述 根据《企业会计准则》以及公司的会计政策、会计估计的相关规定，为客观、 公允地反映公司截至 2024 年 9 月 30 日的财务状况及 2024 年前三季度的经营成果， 本着谨慎性原则，公司对截至 2024 年 9 月 30 日公司及下属子公司的金融资产、存 货和长期资产等进行了全面充分的评估和分析，对可能发生资产减值损失的相关资 产计提减值准备。 经公司测算，本期计提的减值准备总额约为 2,506.30 万元。具体情况如下表所 示： 单位：万元 | 序号 | 项目 | 年前三季度计提金额 2024 | 备注 | | --- | --- | --- | --- | | 1 | 信用减值损失 | 2,186.54 | 应收 ...

证券代码：688315 证券简称：诺禾致源 公告编号：2024-049 北京诺禾致源科技股份有限公司 第三届监事会第十七次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 北京诺禾致源科技股份有限公司（以下简称"公司"）第三届监事会第十七次 会议（以下简称"本次会议"）于 2024 年 10 月 24 日召开，公司已于 2024 年 10 月 18 日以邮件、电话等方式向公司全体监事发出了会议通知。本次会议由监事 会主席李兴园女士召集并主持，应参加本次监事会会议的监事 3 人，实际参加本 次监事会会议的监事 3 人。会议符合《中华人民共和国公司法》和《北京诺禾致 源科技股份有限公司章程》（以下简称"《公司章程》"）及有关法律法规要求。会 议审议并通过了如下议案： 一、审议并通过了《关于公司<2024 年第三季度报告>的议案》 监事会对公司编制的 2024 年第三季度报告提出如下审核意见： 1、公司 2024 年第三季度报告的编制、审议及保密程序符合法律、法规、 《公司章程》和公司内部管理制度各项规定。 2、公司 ...

Revenue and Profit Performance - Revenue for the third quarter reached RMB 522.53 million, a year-on-year increase of 4.68%[2] - Net profit attributable to shareholders of the listed company was RMB 56.53 million, up 12.52% year-on-year[2] - Total revenue for the first three quarters of 2024 reached 1,519,180,271.23 yuan, a 6.3% increase compared to 1,429,077,493.84 yuan in the same period of 2023[12] - Net profit attributable to the parent company's shareholders in the first three quarters of 2024 was 134,455,987.69 yuan, up 7.3% from 125,274,300.39 yuan in the same period of 2023[13] - Revenue for the first three quarters of 2024 reached RMB 782,690,005.45, a 3.1% increase compared to RMB 758,972,944.97 in the same period of 2023[21] - Net profit for the first three quarters of 2024 was RMB 82,183,129.91, a 12% decrease from RMB 93,362,569.63 in the same period of 2023[22] - Sales revenue from goods and services in the first three quarters of 2024 reached 1,439,494,547.64, a slight increase from 1,403,886,793.48 in the same period of 2023[15] - Sales revenue from goods and services in the first three quarters of 2024 was RMB 504,413,959.15, a 32.9% decrease from RMB 751,927,811.58 in the same period of 2023[23] R&D Investment and Expenses - R&D investment for the quarter was RMB 32.27 million, a decrease of 22.34% compared to the same period last year[4] - R&D investment accounted for 6.18% of total revenue, a decrease of 2.15 percentage points year-on-year[4] - R&D expenses for the first three quarters of 2024 decreased by 15.5% to 77,094,646.26 yuan from 91,241,514.74 yuan in the same period of 2023[12] - R&D expenses increased by 24.4% to RMB 51,675,155.49 in the first three quarters of 2024, compared to RMB 41,544,982.76 in the same period of 2023[21] Assets and Liabilities - Total assets at the end of the reporting period were RMB 3.48 billion, a decrease of 3.16% compared to the end of the previous year[4] - Equity attributable to shareholders of the listed company was RMB 2.43 billion, down 1.22% from the end of the previous year[4] - Total assets decreased to 3,480,803,196.01 RMB as of September 30, 2024, compared to 3,594,420,954.11 RMB at the end of 2023[10] - Total liabilities as of the end of Q3 2024 were 1,031,170,984.68 yuan, a decrease of 8.0% compared to 1,120,583,995.29 yuan at the end of Q3 2023[11] - The company's total equity attributable to the parent company's shareholders was 2,427,467,254.85 yuan at the end of Q3 2024, a slight decrease of 1.2% from 2,457,457,998.48 yuan at the end of Q3 2023[11] - Total assets as of September 30, 2024, were 2,693,094,271.74, a decrease from 2,790,423,592.94 at the end of 2023[19] - Total liabilities as of September 30, 2024, were 573,206,904.83, down from 587,220,292.68 at the end of 2023[19] - Total assets as of the end of Q3 2024 were RMB 2,693,094,271.74, a 3.5% decrease from RMB 2,790,423,592.94 at the end of Q3 2023[20] - Equity attributable to shareholders as of the end of Q3 2024 was RMB 2,119,887,366.91, a 3.8% decrease from RMB 2,203,203,300.26 at the end of Q3 2023[20] Cash Flow and Liquidity - Cash and cash equivalents decreased to 358,203,095.52 RMB from 704,728,527.91 RMB at the end of 2023[9] - Net cash flow from operating activities in the first three quarters of 2024 was 38,855,244.60, compared to 37,155,098.63 in the same period of 2023[16] - Cash received from investments in the first three quarters of 2024 was 1,728,418,905.84, up from 1,346,812,462.99 in the same period of 2023[16] - Cash paid for investments in the first three quarters of 2024 was 1,816,991,582.58, a decrease from 1,945,405,220.48 in the same period of 2023[16] - Net cash flow from investing activities in the first three quarters of 2024 was -201,744,126.42, an improvement from -675,346,435.49 in the same period of 2023[16] - Net cash flow from financing activities in the first three quarters of 2024 was -175,317,340.10, compared to -11,681,349.21 in the same period of 2023[16] - The company's cash and cash equivalents at the end of September 2024 were 353,516,728.48, down from 691,622,974.60 at the beginning of the year[17] - Operating cash flow for the first three quarters of 2024 was negative RMB 97,968,148.17, a significant decline from positive RMB 204,792,280.07 in the same period of 2023[23] - Investment cash flow for the first three quarters of 2024 was negative RMB 52,490,344.33, an improvement from negative RMB 244,775,672.35 in the same period of 2023[23] - Cash and cash equivalents at the end of Q3 2024 were RMB 70,664,695.55, a 32.3% increase from RMB 53,431,374.21 at the end of Q3 2023[24] Shareholder and Equity Information - The company's largest shareholder, Li Ruiqiang, holds 51.61% of the shares[6] - The company repurchased 11,141,468 shares, representing 2.68% of the total shares outstanding[7] - Basic earnings per share for the quarter were RMB 0.14, an increase of 7.69% year-on-year[4] - Weighted average return on equity (ROE) for the quarter was 2.32%, a decrease of 0.13 percentage points year-on-year[4] - Basic earnings per share for the first three quarters of 2024 were 0.33 yuan, up 6.5% from 0.31 yuan in the same period of 2023[14] - Total comprehensive income for the first three quarters of 2024 was 139,354,190.77 yuan, a decrease of 2.3% compared to 142,659,082.25 yuan in the same period of 2023[14] - Total comprehensive income for the first three quarters of 2024 was RMB 80,243,004.91, a 14.1% decrease from RMB 93,362,569.63 in the same period of 2023[22] Operating Costs and Expenses - Total operating costs for the first three quarters of 2024 were 1,363,364,801.99 yuan, a 4.6% increase compared to 1,302,778,730.53 yuan in the same period of 2023[12] - Sales expenses for the first three quarters of 2024 increased by 11.7% to 298,100,193.95 yuan from 266,907,751.54 yuan in the same period of 2023[12] Non-Recurring Items - Non-recurring gains and losses for the quarter amounted to RMB 10.83 million, primarily driven by financial asset investment gains and government subsidies[5] Inventory and Accounts Receivable - Accounts receivable increased to 743,599,677.50 RMB from 574,150,299.59 RMB at the end of 2023[9] - Inventory decreased to 173,075,253.90 RMB from 181,513,846.76 RMB at the end of 2023[9] - Accounts receivable as of September 30, 2024, were 591,820,078.84, an increase from 378,711,218.34 at the end of 2023[18] Fixed Assets and Contract Liabilities - Fixed assets increased to 706,001,035.78 RMB from 679,881,094.45 RMB at the end of 2023[10] - Contract liabilities decreased to 714,494,420.60 RMB from 754,971,408.46 RMB at the end of 2023[10] Current and Non-Current Assets - Total current assets decreased to 2,399,707,311.01 RMB from 2,519,240,019.22 RMB at the end of 2023[9] - Total non-current assets increased slightly to 1,081,095,885.00 RMB from 1,075,180,934.89 RMB at the end of 2023[10] Accounts Payable - Accounts payable decreased to 134,186,917.52 RMB from 158,972,532.72 RMB at the end of 2023[10]